Author information:
(1)Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of 
Maryland School of Medicine, Baltimore, Maryland.
(2)University of California Davis Comprehensive Cancer Center, Sacramento, 
California.
(3)University of Turin, Department of Oncology at San Luigi Hospital, Orbassano, 
Italy.
(4)Department of Thoracic Oncology, The Netherlands Cancer Institute and 
Department of Pulmonary Disease, Academic Medical Center, Amsterdam, The 
Netherlands.
(5)Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance 
Publique Hôpitaux de Marseille, Aix Marseille University, Marseille, France.
(6)Department of Medicine, Division of Hematology/Oncology, University of 
California San Francisco, San Francisco, California.
(7)Yale Cancer Center, New Haven, Connecticut.
(8)State Key Laboratory of South China, Hong Kong Cancer Institute, The Chinese 
University of Hong Kong, Hong Kong, China.
(9)Institute of Oncology, Soroka Medical Center and Ben Gurion University, Beer 
Sheva, Israel.
(10)Department of Medicine I, Medical University of Vienna, Vienna, Austria.
(11)Memorial Cancer Institute, Memorial Healthcare System/Florida International 
University (FIU) Miami, Florida.
(12)Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Airway Research 
Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, 
Germany.
(13)Massachusetts General Hospital Cancer Center and Harvard Medical School, 
Boston, Massachusetts.
(14)University Health Network and Princess Margaret Cancer Centre, Toronto, 
Ontario, Canada.
(15)Brigham and Women's Hospital and Department of Pathology, Harvard Medical 
School, Boston, Massachusetts.
(16)National Cancer Centre Singapore and Genome Institute of Singapore, 
Singapore.
(17)Department of Medicine, Division of Oncology, Stanford University School of 
Medicine, Stanford, California.
(18)Department of Translational Molecular Pathology, The University of Texas MD 
Anderson Cancer Center, Houston, Texas.
(19)International Association for the Study of Lung Cancer, Aurora, Colorado.
(20)Division of Medical Oncology, Department of Internal Medicine, The Ohio 
State University, Columbus, Ohio.
(21)Division of Medical Oncology, Department of Medicine, University of Colorado 
Anschutz Medical Campus, Aurora, Colorado, and the International Association for 
the Study of Lung Cancer, Aurora, Colorado. Electronic address: 
Fred.Hirsch@ucdenver.edu.